Another positive announcement.
It's slow and steady but this company has created and building platform technology within the hot medical tech sector, predictive medicine.
Proof of commercialisation is the elephant in the room. With PIQ management suggesting in the recent 1/4ly report commercialisation is possible pre FDA approval i'd expect a commercial arrangement in the USA in the coming months.
With such a tight register any hint of a decent USA revenue stream would catapult us above $2+ imo.
We wait..
Ann: Proteomics identifies novel biomarkers for Asthma and COPD, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $53.96M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 33.0¢ | $48.66K | 145.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1402 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 2822 | 2 |
View Market Depth
| Last trade - 12.53pm 24/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |